Spironolactone use is associated with improved outcomes in patients with heart failure with preserved ejection fraction and concomitant resistant hypertension

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension – Journal of the American Heart Association

Commentary: Spironolactone use associated with improved outcomes for patients with HFpEF and resistant hypertension – 2 Minute Medicine